adplus-dvertising
Close Menu
Breaking News:
Subscribe
Health News Harry MillerBy

Johnson & Johnson’s Single-Shot Vaccine Could Be The Answer To These At-Risk Groups – Refinery29

Johnson & Johnson’s Single-Shot Vaccine Could Be The Answer To These At-Risk Groups – Refinery29


“The potential to significantly reduce the burden of severe disease, by providing an effective and well-tolerated vaccine with just one immunization, is a critical component of the global public health response,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson in a press release. “A one-shot vaccine is considered by the World Health Organization to be the best option in pandemic settings, enhancing access, distribution and compliance.”

Let’s block ads! (Why?)

728x90x4

Source link

Share.

Harry Miller is a writer and editor based in Toronto with 14 years of experience in the journalism industry. Before joining Canada News Media as a National Online Journalist, Miller worked as a senior writer and a reporter-editor with the Canadian Press and as a breaking news reporter with the Toronto Star. At Canada News Media he covers national news and the trending stories Canadians are searching for. Miller holds two bachelor's degrees, one in journalism from Ryerson University and another in communications and film studies from Carleton University.

Related Posts